Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 9;23(7):e257018.
doi: 10.6004/jnccn.2025.7018.

Burden of Chronic Health Conditions Among People With HIV and Common Non-AIDS-Defining Cancers

Gaurav Goyal  1 , Ene M Enogela  2 , Greer A Burkholder  3 , Mari M Kitahata  4 , Heidi M Crane  4 , Vanessa Eulo  1 , Chad J Achenbach  5 , Claire E Farel  6 , Peter W Hunt  7 , Jeffrey M Jacobson  8 , Julia Fleming  9 , Edward R Cachay  10 , Michael S Saag  3 , Smita Bhatia  11 , Joshua Richman  11
Affiliations

Burden of Chronic Health Conditions Among People With HIV and Common Non-AIDS-Defining Cancers

Gaurav Goyal et al. J Natl Compr Canc Netw. .

Abstract

Background: With advances in antiretroviral therapy, aging people with HIV (PWH) are increasingly at risk for non-AIDS-defining cancers (NADCs) and chronic morbidities. This study examines whether PWH with NADCs face a higher risk of new-onset chronic health conditions compared with those without cancer.

Patients and methods: We conducted a retrospective cohort study using data from the CFAR (Centers for AIDS Research) Network of Integrated Clinical Systems (CNICS) for PWH enrolled between 1995 and 2018 from 8 US academic institutions. We included PWH with the 5 most common NADCs: anal cancer, non-small cell lung cancer (NSCLC), prostate cancer, classic Hodgkin lymphoma (HL), and hepatocellular carcinoma (HCC). A 1:2 matching for each NADC subgroup was performed based on age, cohort entry year, and sex (noncancer cohort). Chronic health conditions were graded using the CTCAE, with the primary outcome being the risk of new-onset grade ≥3 morbidities, analyzed using Cox regression.

Results: The study included 693 PWH with NADCs and 1,345 matched PWH without cancer. At a median follow-up of 13.7 years for PWH with NADCs and 10.7 years for the noncancer group, the prevalence of grade ≥3 morbidities was significantly higher in the NADC group (24.8% vs 13.8%; P≤.01). Multivariable Cox regression showed a higher risk of new-onset grade ≥3 conditions in the NADC group (hazard ratio, 2.94; P<.0001), specifically diabetes mellitus (all NADCs), myocardial infarction (NSCLC and HL), and congestive heart failure (prostate cancer).

Conclusions: Our study showed an excess risk of new-onset morbidities among PWH with NADCs. These findings have critical implications for the care of survivors of HIV and cancer and underscore the importance of integrated care approaches to address late effects in this vulnerable population.

PubMed Disclaimer

Conflict of interest statement

Authors' Disclosures of Potential Conflicts of Interest

G.G. has served on advisory board for Opna Bio, Seagen, Electra, and Sobi, and received consulting fee from Recordati.

Figures

Figure 1.
Figure 1.
Flowchart depicting selection of cases (people with HIV [PWH] and non-AIDS defining cancers [NADCs]) and PWH without cancer (non-cancer sample) from CNICS.
Figure 2.
Figure 2.
Cumulative incidence of grade ≥ 3 morbidities among cases (people with HIV [PWH] and non-AIDS defining cancers [NADCs]) and non-cancer PWH.
Figure 3.
Figure 3.
Cumulative incidence of grade ≥ 3 morbidities by cancer type compared with non-cancer cohort.
Figure 4.
Figure 4.
Forest plot depicting the hazard ratio (HR) for new-onset grade ≥ 3 chronic health conditions among people with HIV (PWH) and non-AIDS defining cancers (NADCs) with NADCs compared with the non-cancer cohort.
See this image and copyright information in PMC

References

    1. Collaboration H-C, Ray M, Logan R, et al. The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. AIDS. 2010;24(1):123–137. - PMC - PubMed
    1. Lohse N, Obel N. Update of Survival for Persons With HIV Infection in Denmark. Ann Intern Med. 2016;165(10):749–750. - PubMed
    1. CDC. Diagnoses of HIV infection in the United States and dependent areas, 2019. HIV Surveillance Report. 2021; 32.
    1. Franceschi S, Lise M, Clifford GM, et al. Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer. 2010;103(3):416–422. - PMC - PubMed
    1. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370(9581):59–67. - PubMed

LinkOut - more resources